Profound hearing loss from intravertebral artery cisplatin

Otolaryngol Head Neck Surg. 1997 Feb;116(2):234-7. doi: 10.1016/S0194-59989770332-2.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Astrocytoma / drug therapy*
  • Astrocytoma / pathology
  • Audiometry, Pure-Tone
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology
  • Cisplatin / administration & dosage*
  • Cisplatin / adverse effects*
  • Cisplatin / therapeutic use
  • Fatal Outcome
  • Hearing Loss, Sensorineural / chemically induced*
  • Hearing Loss, Sensorineural / diagnosis
  • Humans
  • Infusions, Intra-Arterial / adverse effects
  • Male
  • Middle Aged
  • Occipital Lobe / pathology
  • Vertebral Artery*

Substances

  • Antineoplastic Agents
  • Cisplatin